Skip to main content
Figure 2 | Cases Journal

Figure 2

From: Sorafenib in a patient with advanced hepatocellular carcinoma and serious impairment of left ventricular function: a case report

Figure 2

Behaviour of left ventricular ejection fraction values during treatment. left ventricular ejection fraction, echocardiographically evaluated every two months for one year during treatment with sorafenib, showed no further drops or significant fluctuations from baseline value. Similarly, the patient remained on good hemodynamic steadiness all treatment long.

Back to article page

Cases Journal

ISSN: 1757-1626